- On November 17, 2026, FDA proposed a rule providing that N-acetyl-L-cysteine (NAC) is not excluded from the definition of a dietary supplement. If finalized, the rule would permit products containing NAC to be lawfully marketed as dietary supplements, provided those products do not otherwise violate the Federal Food, Drug, and Cosmetic Act (FD&C Act).
- Section 201(ff)(3)(B)(i) of the FDC&C Act excludes from the dietary supplement definition an article that is approved as a new drug but was not marketed as a food or dietary supplement before such approval. Since NAC was approved as a drug in 1963, and FDA has not seen evidence of NAC being marketed in a food or dietary supplement before that time, the Agency has long taken the position that NAC is not eligible for use in dietary supplements (even though it otherwise meets the statutory definition). Section 201(ff)(3) of the FD&C Act allows FDA to issue a regulation permitting the use of an otherwise-excluded substance in dietary supplements if the Agency determines that it “would be lawful” under the statute, although FDA has never previously used this authority.
- In 2022, FDA issued guidance detailing the Agency’s intent to exercise enforcement discretion on the sale and distribution of dietary supplements containing NAC, as we previously blogged. According to FDA, enforcement discretion was appropriate due to a lack of identified safety issues, history of use of NAC in dietary supplements, and a strong demand for such use. This guidance followed an Agency determination in response to two citizen petitions that NAC is excluded from the definition of a dietary supplement.
- In the preamble to the proposed rule, FDA determined that Congress intended for two conditions to be satisfied to issue a regulation under Section 201(ff)(3): (1) there would be “adequate safeguards” on the use of the substance in dietary supplements (i.e., appropriate safety) and (2) allowing the dietary supplement use would be “unlikely to impede new drug development.” FDA has proposed that NAC satisfies both conditions.
- Section 301(ll) of the FD&C Act includes similar exclusion language with respect to substances in conventional food (which includes dietary supplements) and a similar opportunity to overcome the exclusion via regulation. FDA is issuing the proposed rule under both the 201(ff)(3) and 301(ll) statutory provisions.
- If the proposed rule is finalized, FDA intends to withdraw the NAC enforcement discretion guidance. FDA is accepting comments on the proposed rule until January 19, 2027. Keller and Heckman would be happy to assist in preparing comments on the proposed rule and will continue to monitor for updates related to the use of NAC in dietary supplements.
State Legislation Update: New York GRAS Bill Heads to Governor While 2027 Prefiling Begins
Posted on
- On November 13, 2026, the New York Legislature delivered the Food Safety and Chemical Disclosure Act (S1239F/A1556G) to Governor Kathy Hochul. The bill would require food companies to report to the New York Department of Agriculture and Markets any ingredients they have self-affirmed as “generally recognized as safe” (GRAS) without notifying FDA, along with the scientific basis for that determination.
- Under the New York Constitution, the Governor has 10 days, excluding Sundays, to sign or veto the bill. If she takes no action, the bill becomes law without her signature. She could also sign it subject to agreed “chapter amendments” that the Legislature would pass next session. If enacted, the law would take effect 180 days after it becomes law, and New York would become the first state to act on GRAS ingredients.
- Meanwhile, states have begun pre-filing for the 2027 legislative session. On November 9, 2026, the first day of prefiling for the 90th Texas Legislature, lawmakers filed more than 1,200 bills. As Texas lawmakers begin prefiling legislation ahead of the 2027 legislative session, several food-related bills are already signaling where policy debates may be headed.
- Below is a look at some of the key food-related proposals introduced so far.
- Food Additives in School Meals. HB 518 would widen Texas’s existing ban on certain additives, such as brominated vegetable oil, Red 40, and Yellow 5. The ban now covers free and reduced-price school meals. The bill would extend it to all meals schools sell during the school day, except food from contracted restaurants or vending machines. The bill builds on SB 314, enacted last session.
- Imported Seafood. HB 451 relates to the labeling and representation of imported fish and shellfish. It follows FDA’s recent draft guidance on U.S.-origin statements for seafood, which stresses that origin claims must be substantiated.
- Folic Acid in Corn Masa. HB 290 would require folic acid fortification of corn masa flour and wet corn masa products made, sold, or used as ingredients in Texas. It would also address how those products are labeled and would create a criminal offense.
- Halal School Meals. HB 401 would require public and charter schools to offer a halal option in breakfast and lunch programs when a student or parent asks, starting in the 2027-28 school year. HB 426 would impose the same requirement only in counties of at least 2.1 million people and the counties next to them.
- Mobile Food Vendors. HB 854 would set up state and local permitting for mobile food vendors, with licensing, fees, and penalties. HB 860 would regulate mobile food vendors and temporary food event operations, and would repeal Chapter 437A of the Health and Safety Code.
- Ultra-Processed Foods Research. SB 288 would direct the Texas Tech University Health Sciences Center to study long-term dietary health trends in Texas, including consumption of ultra-processed foods.
- Keller and Heckman will continue to monitor Governor Hochul’s action on New York’s GRAS bill and the new filings for food-related bills we move toward the 2027 legislative session.
FDA Issues 2026 Retail Food Standards
Posted on
- On November 12, 2026, the U.S. Food and Drug Administration (FDA) issued the 2026 edition of the Voluntary Retail Food Regulatory Program Standards, which defines the key elements of an effective retail food regulatory program that can be adopted by state, local, tribal, and territorial (SLTT) food regulatory agencies.
- The following changes were made to the 2026 edition based on recommendations from the 2025 Conference for Food Protection Biennial Meeting:
- New definition for “Risk Based Inspection”
- New definition for “Intervention Strategy”
- The Retail Program Standards include recommendations for designing and managing retail initiatives, as well as recognizing programs that show progress in implementing the standards. It aligns with the policies provided in the 2026 Food Code, which was just published in September.
- Keller and Heckman will continue to monitor and relay food regulatory updates.
National Organic Standards Board Votes to Recommend Delisting of Carrageenan
Posted on
- At an October meeting, the National Organic Standards Board (NOSB) voted to recommend the delisting of carrageenan from the National List of Allowed and Prohibited Substances (National List) for organic production. Carrageenan is a natural polysaccharide derived from seaweed and currently included in the National List as a permitted nonsynthetic nonagricultural substance (7 CFR 205.605).
- Carrageenan is used for a variety of purposes, including as a thickener, gelling agent, and stabilizer, across a variety of food products, including dairy products, plant-based alternative products, and processed meats. Advocates for its delisting point to what they allege are potential gut inflammatory health concerns. Numerous food safety authorities, including FDA, EFSA, and Health Canada have found that the use of food-grade carrageenan is safe.
- It has been reported that USDA will move forward with NOSB’s recommendation and begin drafting a proposed rule to remove carrageenan from the National List, although USDA has not made any announcement concerning this development.
- The organic listing for carrageenan has a history of controversy. NOSB voted to recommend removal of carrageenan in 2016, but USDA overruled the decision and renewed carrageenan’s organic listing until 2023. In 2021, USDA again renewed the carrageenan listing until 2028.
- Keller and Heckman will continue to monitor and report on the issue.
FDA Revokes Authorizations of Substances for Use in Color Additive Production
Posted on
- On November 9, 2026, FDA announced that it would be revoking the authorization for the use of several substances in the production of color additives in response to color additive petitions submitted by the International Association of Color Additives (IACM) and a group including the Environmental Defense Fund, Breast Cancer Prevention Partners, Center for Environmental Health, Environmental Working Group, and Lisa Lefferts (EDF et al.).
- EDF et al. petitioned FDA to revoke the authorization for the use of methylene chloride as a diluent in inks for marking fruits and vegetables under the Delaney Clause of the Federal Food, Drug, and Cosmetic Act, which prevents the Agency from authorizing an additive that has been found to cause cancer in humans or animals. According to FDA, the Group demonstrated that “this additive induces cancer in laboratory animals.” Based on studies cited in the petition, FDA determined that methylene chloride is an animal carcinogen. Therefore, as a matter of law, the substance is deemed unsafe.
- The EDF et al. petition also included a request to remove ethylene dichloride, methylene chloride, and trichloroethylene from the list of authorized extraction solvents for annatto extract, paprika oleoresin, and turmeric oleoresin, but FDA denied this portion of the petition because residues of these substances would be impurities in the color additives, which are not subject to the Delaney Clause.
- IACM petitioned FDA to revoke the authorization for the use of methylene chloride, ethylene dichloride, and trichloroethylene in the production of annatto extract, paprika oleoresin, and turmeric oleoresin. IACM’s petition demonstrated that industry has abandoned these uses. The petition also requested that FDA remove the use of methylene chloride as a diluent in color additive mixtures in inks for marking fruit and vegetables. However, FDA denied this request as moot because the Agency revoked authorization of this use of the substance in response to the EDF et al. petition.
- Keller and Heckman will continue to monitor updates related to food and color additive authorizations.
FDA Updates Food Allergen Labeling FAQs
Posted on
- The U.S. Food and Drug Administration (FDA) recently updated its Frequently Asked Questions accompanying the agency’s fifth edition Questions and Answers Regarding Food Allergens, Including the Food Allergen Labeling Requirements of the Federal Food, Drug, and Cosmetic Act guidance, originally finalized in January 2025. The October 29, 2026 updates provide additional clarification regarding major food allergen labeling, manufacturing controls, allergen-free claims, and the agency’s revised interpretations of certain allergen categories.
- Consistent with the January 2025 guidance, FDA reiterated that milk from ruminants other than cows (such as goats and sheep) and eggs from birds other than chickens (such as ducks, geese, and quail) are considered major food allergens. FDA also confirmed that ingredient declarations and “Contains” statements should identify the specific animal source, such as “goat milk” or “duck eggs.”
- FDA also provided additional clarification regarding tree nuts. The agency confirmed that coconut and several other tree nuts, including chestnut, pili nut, shea nut, ginkgo nut, and kola nut, are no longer considered major food allergens for labeling purposes. As a result, these ingredients should no longer be declared in a “Contains” statement, although they must still appear in the ingredient list by their common or usual names when used as ingredients.
- Several new FAQs focus on allergen labeling statements and FDA’s expectations regarding potentially inconsistent claims. FDA stated that it is generally not appropriate to use a “wheat-free” claim together with a “may contain wheat” advisory statement, or to pair a “Contains peanuts” statement with a “may contain peanuts” statement. According to FDA, such combinations may provide inconsistent allergen information and raise concerns under the prohibition against false or misleading labeling.
- Keller and Heckman will continue to monitor FDA guidance and policy developments relating to food allergen labeling and food safety compliance and will provide updates on significant developments.
Canada Adds Silicon Dioxide to List of Permitted Anticaking Agents in Nutrient Pre-mixes for Use in Infant Formula
Posted on
- On October 29, 2026, Health Canada expanded the permitted use of silicon dioxide as an anticaking agent in nutrient pre-mixes for use in infant formula. The change was implemented through the addition of paragraph S.1(h) to the List of Permitted Anticaking Agents.
- Silicon dioxide is not intended to perform a technical function in the finished infant formula. Instead, its presence results from carry-over from the nutrient premix, where it helps prevent ingredients from clumping together during manufacturing and handling.
- Silicon dioxide may be used in nutrient premixes at levels consistent with Good Manufacturing Practice, meaning manufacturers may only use the amount necessary to achieve the intended anticaking function. Any residue in infant formula as consumed must not exceed 10 parts per million (ppm).
- The authorization follows Health Canada’s premarket safety assessment, which evaluated dietary exposure, allergenicity, chemistry, nutrition, toxicology, and technical efficacy. Health Canada concluded that the requested use is supported from both safety and technical perspectives, and noted that the 10 ppm residue limit is recognized internationally.
Canadian Study Demonstrates Impact of Canadian FOP Labeling
Posted on
- A study commissioned by Blendtek and conducted independently by Dalhousie University on the impact of Canadian front of pack (FOP) nutrition labels found that FOP labels are significant to Canadian purchasing decisions, but that taste and price are still generally more important. Canadian FOP regulations requiring warnings for most foods “high in” (as defined by regulation) saturated fat, sugar, and/or sodium were published in 2022, but only began to be enforced this year (FOP Guidance). The study is available for download here.
- The study was conducted on a sample of 1,000 Canadian consumers. The study’s findings included the following:
- Awareness of FOP labeling was very high (e.g., 94% of consumers were aware that some foods had FOP labels and 97% said they understood them at least somewhat well).
- More than half of consumers reported changing their behaviors because of an FOP label (e.g., 50% switched from one product to another in the same category because of an FOP label and 64% said that FOP labels were at least somewhat likely to influence future decisions).
- Household characteristics and food category were reported to impact the degree of importance of FOP labels. For example, the study results indicate that households in which someone was following a specific diet were most likely to avoid FOP-labeled foods, while financially strained households were the least likely to avoid them. Snack purchases were the most likely to be influenced by FOP labels.
- Consumers were slightly more responsive to sugar FOP labels than fat or sodium, but no symbol dominated.
- Price and taste remain the most important considerations (taste, price, and nutrition were rated as very or extremely important by 86.2%, 61.4%, and 58.4% of respondents, respectively). Only a small portion of consumers said they will pay more for a comparable product without an FOP label.
- FDA’s 2025 proposed FOP rule would, if finalized, also provide information on saturated fat, sodium, and added sugar content, although it would provide “low,” “medium,” and “high” criteria. There is no timetable for finalizing FDA’s FOP rule, but it is on the Human Foods Program 2026 Priority Deliverables.
UNC, Harvard Launch Initiative Intended to Support UPF Policies
Posted on
- The University of North Carolina at Chapel Hill’s Global Food Research Program and Harvard Law School’s Food Law and Policy Clinic (FLPC) have joined to launch an initiative “intended to provide policymakers and advocates with scientific research, food supply data, and legal expertise to support the development of policies addressing ultra-processed foods (UPFs).” The initiative—the Food Policy Accelerator—will use nutrition science along with legal and policy analysis to aid in developing food labeling, procurement, and nutrition policies.
- Specifically, the Food Policy Accelerator will conduct work including:
- Food supply analysis and nutrition profiling to determine what foods are affected by certain regulations, including availability, affordability, and purchasing patterns, as well as establishing nutritional criteria;
- Policy development and technical assistance, including scientific guidance and feedback on proposed legislation and regulations;
- Legal research and support to help state and local governments navigate legal questions; and
- Developing resources for policymakers to inform regulatory and legislative decisions.
- The initiative was developed amid ongoing federal and state efforts to define and regulate UPFs, including a proposed UPF definition that is in the works and a recent California law establishing a non-UPF certification seal. According to the FLPC Director, “developing effective regulations requires navigating complex legal and scientific questions,” and the initiative is intended to provide that support.
- Keller and Heckman will continue to monitor developments related to UPF policies.
DOJ Signals Broader FDA Disclosure Authority
Posted on
- The U.S. Department of Justice Office of Legal Counsel (OLC) recently issued an opinion concluding that the Food and Drug Administration (FDA) has authority under existing law to amend its regulations to permit broader disclosure of supply chain information during certain food safety events. The opinion addresses circumstances involving foodborne illness outbreaks, recalls, and other situations that may present risks to public health.
- According to the OLC, current FDA regulations generally treat supply chain information, such as the identities and locations of entities within a product’s distribution chain, as confidential commercial information. As a result, FDA’s ability to disclose this information publicly or share it with state and local partners is currently limited except in specific circumstances, such as when disclosure is necessary to effectuate an enforcement action or recall.
- The opinion explains that these regulatory limitations arise primarily from FDA regulations rather than from a statutory prohibition in the Federal Food, Drug, and Cosmetic Act (FDCA). While the Trade Secrets Act generally restricts federal employees from disclosing certain confidential business information, it permits disclosures that are “authorized by law.”
- The OLC concluded that FDA possesses authority under Section 705(b) of the FDCA (21 U.S.C. § 375(b)) to promulgate regulations allowing broader disclosure of information regarding regulated products in situations involving “imminent danger to health” or “gross deception of the consumer.” If FDA were to adopt such regulations, disclosures made pursuant to them would be considered legally authorized and therefore would not violate the Trade Secrets Act.
- Although the opinion does not itself change FDA policy, it provides legal support for future regulatory changes that could expand information sharing during public health emergencies. Any such changes would require FDA to revise its regulations and would remain subject to the statutory limitations set forth in 21 U.S.C. § 375(b), including the requirement that disclosure relate to circumstances involving an imminent danger to health or gross deception of consumers.
- Keller and Heckman will continue to track developments in this area, including any FDA rulemaking or policy changes related to the disclosure of supply chain information during food safety events.